SGRL
NSESGRL
Key statistics
- Open
- ₹684.00
- Day range
- 636.80 – 697.75
- 52-week range
- —
- From 52w high
- —
- Volume
- 41.2K
- Turnover
- ₹2.8Cr
- Delivery
- 56.7%
- Rel volume
- 1.18×
- RSI (14)
- 56.5
- ATR (14)
- 46.97
- SMA 50
- —
- SMA 200
- —
20-day avg 62.0%
Performance
- 1 day
- -0.50%
- 1 week
- -3.44%
- 1 month
- +31.32%
- 3 months
- —
- 6 months
- —
- 1 year
- —
Delivery percentage
- Latest
- 56.7%
- 20-day avg
- 62.0%
- 1-year avg
- 64.9%
- Percentile
- 24th
- Range
- 46.2–80.9%
25 Sept 2026
Against its own sessions
29 sessions
Over the last 20 sessions SGRL settled 62.0% of its traded quantity, which is unusually high for an NSE equity.
What delivery percentage measuresScan the whole market on delivery
Fundamentals
- Market cap
- ₹864.8 Cr
- P/E (TTM)
- —
- EPS (TTM)
- —
- Shares outstanding
- —
- Listed
- 17 Aug 2026
no positive TTM earnings
Classification
- Macro sector
- Healthcare
- Sector
- Healthcare
- Industry
- Pharmaceuticals & Biotechnology
- Basic industry
- Pharmaceuticals
NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.
Growth
- Revenue YoY
- —
- Profit YoY
- —
- Revenue QoQ
- —
- Profit QoQ
- —
- Interest cost YoY
- —
Compound growth
Not enough filed history for a compound growth rate yet.
Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.
About
- ISIN
- INE414Y01015
- Series
- EQ
- History from
- 17 Aug 2026
- Sessions
- 29
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.